A mutant gene long thought to accelerate tumor growth in thyroid cancer patients actually inhibits the spread of malignant cells, showing promise for novel cancer therapies, a Mayo Clinic study has found. To continue reading, click here.
Related Articles Read More >
Cleveland Clinic reports world’s first transcontinental robot-assisted focal therapy procedure for prostate cancer
How Cardiac Dimensions developed the Carillon Mitral Contour System — and makes the nitinol implant in-house
What is nitinol and where is it used?
